Literature DB >> 26748334

Development of a sheep challenge model for Rift Valley fever.

Bonto Faburay1, Natasha N Gaudreault1, Qinfang Liu1, A Sally Davis1, Vinay Shivanna1, Sun Young Sunwoo1, Yuekun Lang1, Igor Morozov1, Mark Ruder2, Barbara Drolet2, D Scott McVey2, Wenjun Ma1, William Wilson2, Juergen A Richt3.   

Abstract

Rift Valley fever (RVF) is a zoonotic disease that causes severe epizootics in ruminants, characterized by mass abortion and high mortality rates in younger animals. The development of a reliable challenge model is an important prerequisite for evaluation of existing and novel vaccines. A study aimed at comparing the pathogenesis of RVF virus infection in US sheep using two genetically different wild type strains of the virus (SA01-1322 and Kenya-128B-15) was performed. A group of sheep was inoculated with both strains and all infected sheep manifested early-onset viremia accompanied by a transient increase in temperatures. The Kenya-128B-15 strain manifested higher virulence compared to SA01-1322 by inducing more severe liver damage, and longer and higher viremia. Genome sequence analysis revealed sequence variations between the two isolates, which potentially could account for the observed phenotypic differences. We conclude that Kenya-128B-15 sheep infection represents a good and virulent challenge model for RVF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Challenge model; Rift Valley fever; Rift Valley fever virus; Sheep; Strains; Viremia

Mesh:

Substances:

Year:  2015        PMID: 26748334     DOI: 10.1016/j.virol.2015.12.003

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  21 in total

1.  Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.

Authors:  Bonto Faburay; William C Wilson; Arss Secka; Barbara Drolet; D Scott McVey; Juergen A Richt
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  A protective bivalent vaccine against Rift Valley fever and bluetongue.

Authors:  Eva Calvo-Pinilla; Alejandro Marín-López; Sandra Moreno; Gema Lorenzo; Sergio Utrilla-Trigo; Luis Jiménez-Cabello; Julio Benavides; Aitor Nogales; Rafael Blasco; Alejandro Brun; Javier Ortego
Journal:  NPJ Vaccines       Date:  2020-07-30       Impact factor: 7.344

3.  Evaluation of Fluorescence Microsphere Immunoassay for Detection of Antibodies to Rift Valley Fever Virus Nucleocapsid Protein and Glycoproteins.

Authors:  I K Ragan; A S Davis; D S McVey; J A Richt; R R Rowland; W C Wilson
Journal:  J Clin Microbiol       Date:  2018-05-25       Impact factor: 5.948

4.  Rift Valley fever virus Gn V5-epitope tagged virus enables identification of UBR4 as a Gn interacting protein that facilitates Rift Valley fever virus production.

Authors:  Nicole Bracci; Cynthia de la Fuente; Sahar Saleem; Chelsea Pinkham; Aarthi Narayanan; Adolfo García-Sastre; Velmurugan Balaraman; Juergen A Richt; William Wilson; Kylene Kehn-Hall
Journal:  Virology       Date:  2022-01-07       Impact factor: 3.616

5.  Assessment of the control measures of the category A diseases of Animal Health Law: Rift Valley Fever.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Simon Gubbins; Alessandro Broglia; Inma Aznar; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-19

Review 6.  Role of animal models in biomedical research: a review.

Authors:  P Mukherjee; S Roy; D Ghosh; S K Nandi
Journal:  Lab Anim Res       Date:  2022-07-01

Review 7.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

8.  Experimental Infection of Domestic Piglets (Sus scrofa) with Rift Valley Fever Virus.

Authors:  Lorelei L Clarke; Daniel G Mead; Mark G Ruder; Deborah L Carter; Jennifer Bloodgood; Elizabeth Howerth
Journal:  Am J Trop Med Hyg       Date:  2021-10-25       Impact factor: 3.707

9.  Experimental Infection of Calves by Two Genetically-Distinct Strains of Rift Valley Fever Virus.

Authors:  William C Wilson; A Sally Davis; Natasha N Gaudreault; Bonto Faburay; Jessie D Trujillo; Vinay Shivanna; Sun Young Sunwoo; Aaron Balogh; Abaineh Endalew; Wenjun Ma; Barbara S Drolet; Mark G Ruder; Igor Morozov; D Scott McVey; Juergen A Richt
Journal:  Viruses       Date:  2016-05-23       Impact factor: 5.048

10.  A Recombinant Rift Valley Fever Virus Glycoprotein Subunit Vaccine Confers Full Protection against Rift Valley Fever Challenge in Sheep.

Authors:  Bonto Faburay; William C Wilson; Natasha N Gaudreault; A Sally Davis; Vinay Shivanna; Bhupinder Bawa; Sun Young Sunwoo; Wenjun Ma; Barbara S Drolet; Igor Morozov; D Scott McVey; Juergen A Richt
Journal:  Sci Rep       Date:  2016-06-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.